Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News Eli Lilly’s Emgality gets FDA green light for migraine prevention Eli Lilly and Company has secured approval from the US Food and Drug Administration (FDA) for its migraine… bypharmanewsdailySeptember 29, 2018
